Nov 22 (Reuters) - Pfizer Inc’s COVID-19 vaccine could get British regulatory approval by the end of the week, The Telegraph reported on Sunday.
British regulators are about to start a formal appraisal of the vaccine by Pfizer and BioNTech SE, with the National Health Service told to be ready to administer the doses by Dec. 1, the Telegraph said bit.ly/3pPb5oF. (Reporting by Ann Maria Shibu in Bengaluru; Editing by Lisa Shumaker)
Reuters Breakingviews is the world's leading source of agenda-setting financial insight. As the Reuters brand for financial commentary, we dissect the big business and economic stories as they break around the world every day. A global team of about 30 correspondents in New York, London, Hong Kong and other major cities provides expert analysis in real time.
Sign up for a free trial of our full service at https://www.breakingviews.com/trial and follow us on Twitter @Breakingviews and at www.breakingviews.com. All opinions expressed are those of the authors.